We've had patients who couldn't tolerate Semaglutide but do beautifully on Tirzepatide, and we've seen the exact opposite happen just as often
The N-terminal domain of BNIP3, a mitochondrial protein, is up-regulated in response to hypoxia and anchored to the OMM through its C-terminal transmembrane (TM) domain, exposing the N-terminal domain to the cytoplasm [11]
doi: 10.1007/s11154-014-9289-5 [DOI] [PMC free article] [PubMed] [Google Scholar] 5.Van Bloemendaal L, Rg IJ, Ten Kulve JS, et al
Once retatrutide is licensed, suspected side effects should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
Journal of Endocrinology and Metabolism, 45(3), 210-225
Insulin resistance as a potential driving force of parental obesity-induced adverse metabolic programming mechanisms in children with obesity